GENERAL AMERICAN INVESTORS CO INC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
GENERAL AMERICAN INVESTORS CO INC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$8,883,000
-14.3%
714,100
-5.7%
0.90%
-15.2%
Q3 2016$10,369,000
+16.9%
757,400
-36.9%
1.06%
+14.6%
Q2 2016$8,868,000
+15.6%
1,200,0000.0%0.92%
+16.7%
Q1 2016$7,668,000
+2.2%
1,200,0000.0%0.79%
+15.1%
Q4 2015$7,500,000
+7.0%
1,200,0000.0%0.69%
+8.9%
Q3 2015$7,008,000
-29.4%
1,200,0000.0%0.63%
-22.5%
Q2 2015$9,924,000
+0.4%
1,200,0000.0%0.82%
+0.2%
Q1 2015$9,888,000
+19.9%
1,200,0000.0%0.81%
+23.5%
Q4 2014$8,244,000
+27.2%
1,200,0000.0%0.66%
+27.7%
Q3 2014$6,480,000
-15.2%
1,200,0000.0%0.52%
-16.9%
Q2 2014$7,644,000
-21.0%
1,200,0000.0%0.62%
-23.2%
Q1 2014$9,672,000
+18.2%
1,200,0000.0%0.81%
+21.8%
Q4 2013$8,184,000
+1.1%
1,200,000
+172.7%
0.66%
-5.7%
Q3 2013$8,096,000
+5.2%
440,0000.0%0.70%
+0.6%
Q2 2013$7,696,000440,0000.70%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$69,390,00026.80%
Opaleye Management Inc. 1,500,000$8,100,000,0006.31%
Camber Capital Management LP 6,000,000$32,400,0003.04%
Ghost Tree Capital, LLC 700,000$3,780,0002.05%
Granite Point Capital Management, L.P. 700,000$3,780,0001.88%
Duquesne Family Office 1,645,000$8,883,0001.09%
Geduld E E 272,200$1,470,0001.04%
Elk Creek Partners, LLC 659,232$3,560,0000.93%
Palo Alto Investors LP 2,231,717$12,051,0000.90%
HighVista Strategies LLC 1,200,000$6,480,0000.87%
View complete list of ARIAD PHARMACEUTICALS INC shareholders